Radnostix Reports Sharply Increased Q1 Loss, Revenue Decline Amid Product Recalls and Terminated Asset Sale
INIS has more than doubled off its 52-week low of $0.035.
Summary
Radnostix Inc. announced a significantly wider net loss and lower revenue in Q1 2026, impacted by product recalls and the termination of a major asset sale, highlighting ongoing financial and operational challenges.
Key Events · Earnings and Guidance · INIS
-
Net Loss Surges
Net loss for Q1 2026 increased to $1.35 million, a 1,096% increase compared to a net loss of $0.11 million in Q1 2025.
-
Revenue Declines Significantly
Total product sales decreased by 27% to $2.38 million in Q1 2026 from $3.24 million in the same period last year.
-
Product Recalls Impact Sales
Two voluntary product recalls in Q1 2026 resulted in $60,000 in lost revenue from one batch, an ongoing $65,000 weekly sales loss, $50,000 in customer credits, and a $75,000 inventory write-off.
-
$12.5M Asset Sale Terminated
The company mutually terminated a $12.5 million asset purchase agreement for its Fluorine Products segment and Uranium De-Conversion Facility on March 11, 2026, citing low confidence in the buyer's funding. This was previously announced in an 8-K on March 16, 2026.
Analysis · INIS · Industrial Applications And Services
Radnostix Inc. reported a substantial increase in net loss and a significant drop in revenue for Q1 2026, driven by product recalls and operational shutdowns. The termination of a $12.5 million asset sale further exacerbates liquidity concerns, despite a temporary extension of preferred stock redemption. The company continues to face supply chain challenges and regulatory scrutiny from the FDA.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 35.7% of the 1024 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, INIS was trading at $0.08 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $42.3M. The 52-week trading range was $0.03 to $0.11. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.